Assertio Therapeutics (NASDAQ:ASRT) Trading Down 6.7%

Share on StockTwits

Assertio Therapeutics, Inc. (NASDAQ:ASRT) was down 6.7% on Friday . The company traded as low as $0.89 and last traded at $0.90, approximately 585,979 shares were traded during mid-day trading. A decline of 62% from the average daily volume of 1,553,827 shares. The stock had previously closed at $0.97.

A number of analysts recently weighed in on ASRT shares. Brookline Capital Management started coverage on Assertio Therapeutics in a report on Wednesday, June 3rd. They issued a “buy” rating and a $3.50 price objective for the company. Zacks Investment Research downgraded Assertio Therapeutics from a “strong-buy” rating to a “hold” rating in a report on Friday, May 15th.

The stock has a fifty day simple moving average of $0.88 and a two-hundred day simple moving average of $0.94.

Assertio Therapeutics (NASDAQ:ASRT) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.18. Assertio Therapeutics had a negative return on equity of 110.00% and a negative net margin of 83.99%. The firm had revenue of $20.92 million during the quarter, compared to the consensus estimate of $11.30 million. As a group, equities research analysts expect that Assertio Therapeutics, Inc. will post -1.56 EPS for the current year.

A number of institutional investors have recently modified their holdings of the business. Nisa Investment Advisors LLC grew its holdings in Assertio Therapeutics by 20.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 75,888 shares of the company’s stock worth $65,000 after acquiring an additional 12,968 shares during the period. Ahrens Investment Partners LLC acquired a new stake in Assertio Therapeutics during the 2nd quarter worth about $51,000. TSP Capital Management Group LLC grew its holdings in Assertio Therapeutics by 84.4% during the 2nd quarter. TSP Capital Management Group LLC now owns 504,400 shares of the company’s stock worth $432,000 after acquiring an additional 230,800 shares during the period. Finally, Lenox Wealth Advisors LLC acquired a new stake in Assertio Therapeutics during the 2nd quarter worth about $427,000. Hedge funds and other institutional investors own 65.98% of the company’s stock.

About Assertio Therapeutics (NASDAQ:ASRT)

Assertio Therapeutics, Inc, a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; and Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults.

Featured Article: Mutual funds are not immune from market timing

Receive News & Ratings for Assertio Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assertio Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Invitation Homes Inc  Shares Acquired by ProShare Advisors LLC
Invitation Homes Inc Shares Acquired by ProShare Advisors LLC
Coastal Capital Group Inc. Sells 19 Shares of Amazon.com, Inc.
Coastal Capital Group Inc. Sells 19 Shares of Amazon.com, Inc.
Amazon.com, Inc.  Stock Position Lifted by K.J. Harrison & Partners Inc
Amazon.com, Inc. Stock Position Lifted by K.J. Harrison & Partners Inc
Quantitative Systematic Strategies LLC Purchases New Stake in BJs Wholesale Club Holdings Inc
Quantitative Systematic Strategies LLC Purchases New Stake in BJs Wholesale Club Holdings Inc
Quantitative Systematic Strategies LLC Buys New Position in Nokia Oyj
Quantitative Systematic Strategies LLC Buys New Position in Nokia Oyj
Probity Advisors Inc. Sells 4 Shares of Amazon.com, Inc.
Probity Advisors Inc. Sells 4 Shares of Amazon.com, Inc.


© 2006-2020 Ticker Report